The Pandemic Antiviral Discovery Fund aims to mirror its vaccines counterpart CEPI, advancing drugs to phase II development to be ready for when the next pandemic strikes
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.